Comment on CMS-2026-1255-0001

Summary: The EveryLife Foundation for Rare Diseases supports the proposed rule's improvements to interoperability and prior authorization standards but argues that the rule should go further to protect rare disease patients. They specifically recommend shorter response timelines, clearer definitions for "urgent" requests, protections against repeated reauthorizations, and increased accountability for noncompliance.